Nicotinamide and Nonmelanoma Skin Cancers.
Ophthalmic Plast Reconstr Surg
; 38(3): 304-305, 2022.
Article
em En
| MEDLINE
| ID: mdl-35170567
ABSTRACT
Oral nicotinamide supplementation may have the potential to reduce the incidence of non-melanoma skin cancers, and although currently unproven, given its favorable side effect profile, supplementation should be considered seriously, particularly in high-risk individuals.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Neoplasias Cutâneas
/
Melanoma
Tipo de estudo:
Incidence_studies
/
Prognostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2022
Tipo de documento:
Article